top of page

Precision  delivery  of  devices,  drugs,  gene,  cell  and  cell-free  therapies

Interventional Radiologists can access almost any part of the human body without the need for conventional open surgical techniques. As such, they are poised to change the way patients can be treated, given they can locally deliver drug, gene, cell and cell-free therapies directly to affected organs using image-guided endovascular (i.e. within blood vessels), percutaneous (i.e. through the skin), endoluminal (i.e. within the bowel, respiratory or urinary system), and even using device implantation (i.e. bioscaffolds) approaches. These Precision Delivery  approaches overcome many of the issues related to conventional systemic delivery of therapies which includes: first-pass drug metabolism, off-target side effects, lung entrapment of cellular therapies and liver/spleen entrapment of nano or micro scale cell-free and gene-vector therapies.

Given our disease agnostic approach, we focus on each organ system separately to develop “out-of-the-box delivery strategies” that use novel innovative technologies to:

 

(i) gain access to organ and

(ii) modulate microenvironments to make them receptive to therapies

conventional.jpg

Conventional Systemic Administration

vs

LIVER

HEART

Endovascular2.jpg

BRAIN

PERIPHERAL LUNGS

PANCREAS

SPLEEN

LIVER

KIDNEY

PERIPHERAL VASCULAR

HEART

Precision Delivery

IRIS PUBLICATIONS

LATEST NEWS

IRIS Signature.png
1 Stanford University.png
2 Stanford Medicine.png
3 Stanford Health Care.png
4 Stanford Children's Health.png
5 Lucile Packard small.png
6 Stanford MCHRI.png
7 Stanford Canary center.png
8 Stanford MIPS.png
9 Stanford Biodesign.png
10 Stanford Bio-X.png
11 Stanford SDRC.png
12 Stanford CVI.png
13 Stanford Spark.png
14 Eureka Institute.png
15 Stanford Wu Tsai Neuro.png
bottom of page